Practical guidance on the use of sacubitril/valsartan for heart failure

Sacubitril/valsartan is a first-in-class angiotensin receptor-neprilysin inhibitor (ARNI) that has been recommended in clinical practice guidelines to reduce morbidity and mortality in patients with chronic, symptomatic heart failure (HF) with reduced ejection fraction (HFrEF). This review provides...

Descripción completa

Detalles Bibliográficos
Autores principales: Sauer, Andrew J., Cole, Robert, Jensen, Brian C., Pal, Jay, Sharma, Nakul, Yehya, Amin, Vader, Justin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394573/
https://www.ncbi.nlm.nih.gov/pubmed/30565021
http://dx.doi.org/10.1007/s10741-018-9757-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394573/
https://www.ncbi.nlm.nih.gov/pubmed/30565021
http://dx.doi.org/10.1007/s10741-018-9757-1

Ejemplares similares